Shanghai Aladdin Biochemical Technology (SH:688179) Xin Lang Zheng Quan·2025-08-22 03:45Core Viewpoint - Aladdin's stock has shown a significant increase in price and trading activity, indicating positive market sentiment and potential growth opportunities for investors [1][2]. Company Overview - Shanghai Aladdin Biochemical Technology Co., Ltd. was established on March 16, 2009, and went public on October 26, 2020. The company is located at 36 Nanta, New Jinqiao Road, Pudong New District, Shanghai [1]. - The main business activities include research, production, and sales of reagents, with revenue composition as follows: high-end chemicals 42.21%, life sciences 32.73%, analytical chromatography 13.78%, materials science 7.55%, laboratory consumables 2.01%, and others 1.72% [1]. Financial Performance - For the period from January to March 2025, Aladdin achieved a revenue of 130 million yuan, representing a year-on-year growth of 32.20%. The net profit attributable to shareholders was 24.18 million yuan, reflecting a year-on-year increase of 41.35% [2]. - Since its A-share listing, Aladdin has distributed a total of 241 million yuan in dividends, with 150 million yuan distributed over the past three years [3]. Shareholder Structure - As of March 31, 2025, the number of shareholders increased to 10,100, up by 6.08% from the previous period. The average circulating shares per person decreased by 5.73% to 27,331 shares [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by China Europe Medical Health Mixed A (003095) by 3.37 million shares, and new entries from China Europe Innovation Future Mixed (LOF) (501208) and China Europe Science and Technology Theme Mixed (LOF) (501081) [3].